| 1 |
Increased a-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir |
|
|
| Caitlyn Fastenau, Jessica L. Wickline, Sabrina Smith, Kristian F. Odfalk, Leigh Solano, Kevin F. Bieniek, Sarah C. Hopp |
|
| GeroScience. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Fighting the flu: a brief review on anti-influenza agents |
|
|
| Sambuddha Chakraborty, Ashwini Chauhan |
|
| Biotechnology and Genetic Engineering Reviews. 2023; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Breakthrough of glycobiology in the 21st century |
|
|
| Gehendra Mahara, Cuihong Tian, Xiaojia Xu, Jinxiu Zhu |
|
| Frontiers in Immunology. 2023; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Targeting cancer-associated glycans as a therapeutic strategy in leukemia |
|
|
| Ashraf Abdullah Saad |
|
| All Life. 2022; 15(1): 378 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis |
|
|
| Irina G. Luzina, Erik P. Lillehoj, Virginia Lockatell, Sang W. Hyun, Katerina N. Lugkey, Akihiro Imamura, Hideharu Ishida, Christopher W. Cairo, Sergei P. Atamas, Simeon E. Goldblum |
|
| Journal of Pharmacology and Experimental Therapeutics. 2021; 376(1): 136 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
A Comparative Analysis on Four European Countries COVID-19 Response: Focused on the 1st Wave |
|
|
| Eunsol Song, Juhyun Moon, Ji-Hye Byun, Jina Jun, Nam-soon Kim |
|
| Health Insurance Review & Assessment Service Research. 2021; 1(1): 50 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Ensuring Prevention Science Research is Synthesis-Ready for Immediate and Lasting Scientific Impact |
|
|
| Emily A. Hennessy, Rebecca L. Acabchuk, Pieter A. Arnold, Adam G. Dunn, Yong Zhi Foo, Blair T. Johnson, Sonya R. Geange, Neal R. Haddaway, Shinichi Nakagawa, Witness Mapanga, Kerrie Mengersen, Matthew J. Page, Alfredo Sánchez-Tójar, Vivian Welch, Luke A. McGuinness |
|
| Prevention Science. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Perspective sur la responsabilité de l’industrie pharmaceutique dans la promotion de la recherche pédiatrique et dans l’accès aux médicaments essentiels |
|
|
| Neyla Dahane, Béatrice Godard |
|
| Global Health Promotion. 2021; 28(3): 78 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Method Development and Validation for the Trace Level Quantification of Genotoxic Impurity Oseltamivir Phosphate Related Compound-a in Oseltamivir Phosphate Using LC-MS |
|
|
| Pikkili Viswanath, Doddipalli Venkata Ramana Reddy, Nagaraju Chamarthi |
|
| Oriental Journal Of Chemistry. 2021; 37(5): 1192 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia |
|
|
| Narongdet Kositpantawong, Smonrapat Surasombatpattana, Pisud Siripaitoon, Siripen Kanchanasuwan, Thanaporn Hortiwakul, Boonsri Charernmak, Ozioma Forstinus Nwabor, Sarunyou Chusri, Robert Jeenchen Chen |
|
| PLOS ONE. 2021; 16(12): e0261411 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
O “kit-covid” e o Programa Farmácia Popular do Brasil |
|
|
| Cláudia Du Bocage Santos-Pinto, Elaine Silva Miranda, Claudia Garcia Serpa Osorio-de-Castro |
|
| Cadernos de Saúde Pública. 2021; 37(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza |
|
|
| Doreen Szollosi, Ashley Bill |
|
| Current Drug Targets. 2020; 21(2): 202 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Covid-19: What now for remdesivir? |
|
|
| Jeremy Hsu |
|
| BMJ. 2020; : m4457 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases |
|
|
| Mario Bermúdez de León, Rafael B. R. León-Cachón, Beatriz Silva-Ramírez, Rosa Nelly González-Ríos, Brenda Escobedo-Guajardo, Roberto Leyva-Parra, Benjamín Tovar-Cisneros, Everardo González-González, Abdiel Alvarado-Díaz, Ofelia Vázquez-Monsiváis, Viviana Mata-Tijerina, Lorena Puente-Lugo, Erick Álvarez-Galván, María José Currás-Tuala, Miguel Aguado-Barrera, Fabiola Castorena-Torres, Juan Manuel Alcocer-González, Guillermo Elizondo, Ana María Salinas-Martínez |
|
| The Pharmacogenomics Journal. 2020; 20(4): 613 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews |
|
|
| Nayoung Han, Jung Mi Oh, In-Wha Kim |
|
| Scientific Reports. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Radical Approaches During Unusual Circumstances: Intellectual Property Regulation and the COVID-19 Dilemma |
|
|
| Mohammed El Said |
|
| Development. 2020; 63(2-4): 209 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
